KV Pharmaceutical Enters Into Agreement With US Department Of Justice
As per the terms of the settlement, Ethex will plead guilty to criminal charges, and will be required to pay a fine and restitution of $25.8m. Ethex also
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.